https://scholars.lib.ntu.edu.tw/handle/123456789/580598
標題: | Establishment of an immunocompetent metastasis rat model with hepatocyte cancer stem cells | 作者: | CHE LIN | 關鍵字: | CD133 antigen; epithelial cell adhesion molecule; glutathione transferase P1; Hermes antigen; retrorsine; sorafenib; Thy 1 membrane glycoprotein; animal cell; animal experiment; animal model; animal tissue; Article; cancer stem cell; cell differentiation; cell self-renewal; concentration response; controlled study; disease marker; drug screening; gene expression; HTC cell line (hepatocellular carcinoma); immunocompromised patient; immunofluorescence; in vitro study; in vivo study; incubation time; liver cell; liver cell carcinoma; logistic regression analysis; machine learning; male; metastasis potential; microarray analysis; mitochondrial respiration; nonhuman; random forest; rat; staining; support vector machine; TW 1 cell line; Western blotting | 公開日期: | 2020 | 卷: | 12 | 期: | 12 | 起(迄)頁: | 1-14 | 來源出版物: | Cancers | 摘要: | Hepatocellular carcinoma (HCC) is one of the leading causes of cancer mortality. Cancer stem cells (CSCs) are responsible for the maintenance, metastasis, and relapse of various tumors. The effects of CSCs on the tumorigenesis of HCC are still not fully understood, however. We have recently established two new rat HCC cell lines HTC and TW-1, which we isolated from diethylnitrosamine-induced rat liver cancer. Results showed that TW-1 expressed the genetic markers of CSCs, including CD133, GSTP1, CD44, CD90, and EpCAM. Moreover, TW-1 showed higher tolerance to sorafenib than HTC did. In addition, tumorigenesis and metastasis were observed in nude mice and wild-type rats with TW-1 xenografts. Finally, we combined highly expressed genes in TW-1/HTC with well-known biomarkers from recent HCC studies to predict HCC-related biomarkers and able to identify HCC with AUCs > 0.9 after machine learning. These results indicated that TW-1 was a novel rat CSC line, and the mice or rat models we established with TW-1 has great potential on HCC studies in the future. ? 2020 by the authors. Licensee MDPI, Basel, Switzerland. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097773199&doi=10.3390%2fcancers12123721&partnerID=40&md5=5872ecdd1e9b18d70b1db339f8cf0cd2 https://scholars.lib.ntu.edu.tw/handle/123456789/580598 |
ISSN: | 20726694 | DOI: | 10.3390/cancers12123721 | SDG/關鍵字: | CD133 antigen; epithelial cell adhesion molecule; glutathione transferase P1; Hermes antigen; retrorsine; sorafenib; Thy 1 membrane glycoprotein; animal cell; animal experiment; animal model; animal tissue; Article; cancer stem cell; cell differentiation; cell self-renewal; concentration response; controlled study; disease marker; drug screening; gene expression; HTC cell line (hepatocellular carcinoma); immunocompromised patient; immunofluorescence; in vitro study; in vivo study; incubation time; liver cell; liver cell carcinoma; logistic regression analysis; machine learning; male; metastasis potential; microarray analysis; mitochondrial respiration; nonhuman; random forest; rat; staining; support vector machine; TW 1 cell line; Western blotting |
顯示於: | 電機工程學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。